Categories
Blog Education Featured

Can CBD Relieve Your Seasonal Allergies?

What are Seasonal Allergies?

 

Allergy symptoms occur when your immune system responds to foreign material, aka an allergen. That may be something you ingest, inhale, inject into your bloodstream, or come into contact with. According to the American College of Allergy, Asthma, and Immunology, allergies are the 6th leading reason behind chronic illness in the U.S. 

 

Seasonal allergies, in particular, which are more famously known as hay fever, are one of the most common kinds of allergies around. Hay fever is the immune system’s reaction to air saturated with pollen from wind-pollinated plants like trees, grasses, and weeds. Sneezing, stuffy nose, watery eyes, itchy sinuses, throat or ear canals, ear inflammation, and postnasal discharge are among the most frequent symptoms which vary in severity. Headaches, shortness of breath, wheezing, and coughing can also occur.

 

Current Treatment of Seasonal Allergies

 

Despite allergies being so common amongst the world’s population, there is no absolute cure. Allergies, or ‘allergic rhinitis’, are mainly managed by avoiding triggers and relieving symptoms. For example, steering clear of cigarette smoke and pollen. People do so by using HEPA filters in their air conditioning instead of fans in the spring and summer. Another practice is staying home when pollen counts are high and closing windows.

 

Other medical options include prescription drugs and over-the-counter decongestants, and antihistamines, such as Zyrtec and Benadryl. Sometimes allergy shots are prescribed in extreme cases. But most allergy drugs have nasty side effects like dizziness and confusion. Another alternative has come up without any noticeable side effects which has been revealed to be CBD oil.

 

CBD as Allergies Symptoms Reliever 

 

Cannabidiol, or CBD, an active ingredient derived from the hemp plant, is receiving more attention as people become more aware of the medicinal benefits of cannabis. CBD oil has very low amounts of THC, so it won’t get you high. However, while CBD research is still in its initial phases, some studies show promising results on possible health benefits, including chronic pain management, stress relief and combating reactions to allergens.

 

A study published in 2005 revealed that CBD has immunosuppressive and anti-inflammatory properties across cells of the respiratory system. So it may function as a natural antihistamine. CBD and other anti-inflammatories can help to manage some of the more severe reactions and alleviate symptoms such as inflammation around the nose, throat, and mouth. It can be ingested through tinctures/oils, vaping, edibles, or capsules to avoid any irritation. 

 

CBD also helps control the activity and development of white blood cells that respond when the body is exposed to allergens according to a 2009 study. Which is another reason why it may be an effective therapy for seasonal allergies. In addition, CBD has been reported to prevent the blocking of airways and nasal congestion that typically results in coughing and breathing problems.

 

Another study published in 2014 found that A-Pinene, a terpene, was found to be a promising anti-allergic agent. A-Pinene is characterized by a powerful pine and sage aroma that demonstrated a decrease in some symptoms of allergic rhinitis in mice. This research suggests it may be useful in the clinical management of allergic rhinitis, therefore the ability to moderate the unbearable allergy season. Pinene may also help additional symptoms of allergies since it serves as an anti-inflammatory and bronchodilator.

 

You can use CBD oil along with or instead of traditional allergy therapies. As always, consulting with a medical professional is recommended; however Realm of Caring has resources such as this CBD dosage explainer to help you get started in this process. There is a lot to consider when starting cannabinoid therapy and a Realm of Caring care specialist is here to help with your questions. Contact us today by calling (719) 347-5400 or by emailing info@realmofcaring.org.

 

◾

 

Disclaimer

 

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

 

 

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

Categories
Blog Education

Brain Tumor & Cannabinoid Therapy Research

“Go gray in May” represents bringing awareness to the brain tumors that affect nearly 700,000 individuals in the United States today. If you are affected by a brain tumor or know someone who is, we have resources to support and help you to increase your quality of life.

 

In this blog, for Brain Tumor Awareness Month, we aim to answer your questions about brain tumors and cannabinoid therapy research. For those new to this plant-based therapy, just know that you are not alone. Realm of Caring is here to navigate this difficult journey with you. 

 

Terms to know:

 

Endocannabinoid System (ECS): Largest neurotransmitter system in the body, composed of endogenous cannabinoids, cannabinoid receptors, and metabolizing enzymes. It helps the body to maintain biological harmony across all major body systems. 

Endogenous cannabinoids (endocannabinoids): Cannabinoids produced naturally within the body that bind to or modulate receptors present all throughout the body. Examples include anandamide (AEA) and 2-arachidonoylglycerol (2-AG). 

Phytocannabinoids: Cannabinoids found in cannabis plants such as Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD). 

 

How they may help:

 

Tumor angiogenesis is the growth of new blood vessels that are needed to increase tumor size. Therefore, antiangiogenic properties are correlated with suppressing tumors or halting their growth. The antiangiogenic activity of cannabinoids has been well-researched. The anti-tumor effects of THC, CBD, endocannabinoids AEA and 2-AG, and synthetic cannabinoids have been clinically studied for decades now. Recently, more phytocannabinoids are being researched for like-benefits. The ability of these cannabinoids to modulate cell survival and death, as it relates to tumor and cancer growth, has been considered as “significant from a drug development perspective”. 

 

There is a large body of data with solid scientific evidence that points to the role of the ECS in tumor generation and progression. The introduction of cannabinoids to the ECS has resulted in the inhibition of tumor growth as well as suppression of malignant cell growth and cancer cell death. The combination has shown promising efficacy against glioma among other tumor and cancer types. 

 

The cannabinoids that have been used to study these effects also show the ability to decrease negative side effects of conventional cancer therapies as well as having an acceptable safety profile. It is believed that cannabinoids are safe to take in conjunction with traditional cancer therapies. Talking with a doctor is always suggested, but research does suggest that cannabinoids may actually increase the effectiveness of chemotherapy and radiation treatments. 

 

Current strategies to combat cancer utilize combined therapies, to target cancer cells and tumor growth. The idea is that cannabinoids with other anticancer agents work together to slow down or cease the progression. One combined approach includes a 1:1 ratio of CBD:THC. Administering the two together may potentiate each other’s ability. Anecdotally, many cancers respond to this ratio well although the exact milligram needed to be an antiangiogenic or cause apoptosis is unknown and can vary depending on the cancer type and stage. 

 

Realm of Caring has Cancer Dosing Guidelines to help you get started in this process. There is a lot to consider when starting cannabinoid therapy but, as always, a Realm of Caring care specialist is here to help with your questions. Contact us today by calling (719) 347-5400 or by emailing info@realmofcaring.org

 

 

Disclaimer

 

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

 

 

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

 

Categories
Blog Education

Spring Cleaning: How to donate or dispose of unused medication

Categories
Blog Education

Diversity Month: Creating Opportunity and Inclusion in the Cannabis Industry

Categories
Blog Education Featured Uncategorized

April 7th remembered as Charlotte Figi Day in Colorado House and Senate

Categories
Blog Education Featured Uncategorized

Eight Years in the Making: Realm of Caring’s Impact Over Time

Categories
Blog Featured Uncategorized

Rock the RoC

Rock the RoC is a virtual, memorial and benefit concert to pay tribute to Charlotte Figi. Here is what you should know about the April 7th event, the impactful story behind it and how YOU can get involved. 

 

Rock the RoC: 04/07 at 6pm MT – Livestreaming at www.rocktheroc.org 

 

Get your free tickets NOW to the largest event Realm of Caring (RoC) has ever hosted; an event that we know you will love: Rock the RoC. We have curated the perfect playlist, to come together to heal, inspire, and groove. We are excited to share this epic event of award-winning artists with our global community. 

 

You will see performances and appearances by: The Avett Brothers, Jason Mraz, Dr. Sanjay Gupta, Ruthie Foster, Michael Franti, Molly Tuttle, Glen Phillips, Graham Nash, Wesley Schultz of the Lumineers, Sarah Jarosz, Jeffrey Gaines, MC Flow, The War and Treaty, Nora Brown, Johnnyswim, Chris Trapper, and Johnny Helm. 

 

 

Online streaming is free for everyone. But in order to really get this going, we are speaking out to YOU, our global community.

 

Why is that?

 

Well, if you want to see this production come to life, we need your help. 

 

But first…

 

A few words about Remarkable Charlotte:

 

Charlotte Figi shifted the paradigm of wellness and access for all, as the world watched through the expert eyes of Dr. Sanjay Gupta and his truth-seeking docuseries, Weed. Her story of reclaiming a quality of life from pediatric epilepsy with cannabinoid therapy sparked a global effort to showcase the power of cannabis as a natural solution. Her story changed the course of compassionate care for the world. Charlotte’s sudden and tragic passing at the age of thirteen on April 07, 2020, is an urgent reminder that life is precious, that dignity of choice is critical, and that the courage of innocence is a guidepost for human wellness. 

 

 

Who is RoC?

 

RoC is a high-impact nonprofit that is creating a worldwide community where access to plant-based therapies is the cornerstone of helping others. Charlotte’s impact remains the footprint of our path forward, toward care for all through the healing power of the Earth. Her fight paved the foundation for research, education, and impact; our mission carries on her light and legacy through funding research, education, and community services that change lives and open minds. 

 

How can you help?

 

In a VARIETY of ways. Not only will your contribution go towards funding this massive production that is gearing up to air, but it also helps RoC to continue our mission of helping millions globally every day. 

 

Sponsor

Share your brand with millions in the most meaningful and impactful way, celebrating the life of Charlotte. Her life propelled progress for botanical solutions and advocacy for access to them. Your support helps to elevate our mission that began with Charlotte. We have three sponsorship levels available, each incentivized to put your business in the spotlight.   

 

Crowdfunding

Consider making a donation and sharing our Kickstarter Campaign. Rewards for backing this campaign include merchandise with our concert logo, designed by Shepard Fairey’s Studio Number One. Kickstarter funds raised (are required) to go to the production costs of the event. 

 

 

Donate

Not interested in the incentives but love the RoC and want to keep it going? Donate directly to realmofcaring.org just once or monthly in the amount that you are able to provide. Our one on one support services to clients worldwide are completely free, donations help us to keep it that way. 

 

Share your smile!

Be a beacon of light just like Charlotte and share your name or your loved one’s name in a quick video saying “Hi my name is ____ from _____ and I rock the RoC for _______!”. Send us your video to rock@realmofcaring.org and post it to your social media with the hashtag #iROCKtheRoC.

 

Leave a message 

What are your memories of Charlotte? How has your life been impacted by her light? If you wish to share your feelings and thoughts, head to CharlotteFigi.com and leave your personal message there.

 

April 7th, 2021 at 6pm MT is a date and time you do not want to miss. Celebrate our light, Charlotte Figi and the millions around the globe just like her. 

 

Categories
Blog Education

Getting to Know Delta-8-THC

Delta-8-Tetrahydrocannabinol (delta-8-THC) is a cannabinoid that is growing in popularity due to its accessibility in the hemp industry. It is less psychotropic and chemically more stable than its isomer Delta-9-Tetrahydrocannabinol (delta-9-THC), while still having its own researched benefits. 

 

Delta-8-THC and Delta-9-THC are practically identical. They have the same molecular formula of C21H30O2; which also happens to be the same molecular formula as cannabinoids cannabichromene (CBC) and cannabidiol (CBD), and the hormone progesterone. Their metabolisms follow the same pathways and they have been researched for their like-benefits, as they both have an affinity for CB1 receptors in the brain. For example, both delta-8-THC and delta-9-THC have been studied for their benefits as antiglaucoma agents and for their ability to reduce tumor growth in rodent models. While their chemical behavior is very similar in most cases, there are a few chemical differences that set delta-8-THC and delta-9-THC apart.

 

First, delta-8-THC is less psychoactive than delta-9-THC, resulting in individuals being able to tolerate higher amounts per administration. In one study, children with hematologic cancers were able to take considerably higher doses of delta-8-THC than delta-9-THC to prevent vomiting due to antineoplastic treatment. They were administered 480 treatments of delta-8-THC and all participants reported feeling relief. This shows promise for delta-8-THC as an effective, yet inexpensive, option to relieve pediatric cancer patients of their nausea and vomiting from chemotherapy, with negligible side effects.

 

Another difference between the two are their chemical stability and how they are extracted. Delta-9-THC will readily oxidize to cannabinol (CBN) with oxygen, light, or natural aging. Delta-8-THC, on the other hand, is a stable molecule with a long shelf life. Although stable, extracting delta-8-THC is not quite as simple. Delta-8-THC grows in very small amounts in cannabis, however it may be able to be derived from hemp or from CBD; which also makes it technically legal in several states. Many delta-8-THC products are created synthetically by converting CBD into delta-8-THC through a process Dr. Raphael Mechoulam patented, called isomerization. 

 

A few other differences to mention are some advantages that delta-8-THC may have. A study published in 2004 tested small amounts of delta-8-THC in mouse models for its effect on cognitive function and food consumption. Over the course of the study, delta-8-THC showed a tendency to improve cognitive function without the psychoactive effects that are typically associated with cannabis. Food intake increased with a similar performance to delta-9-THC but at a significantly higher rate, showing delta-8-THC as having therapeutic potential for weight disorders. 

 

A question you may be curious about is: will delta-8-THC show up on a drug test that is looking for delta-9-THC? And the answer is, most likely. After cannabinoids are metabolized they are excreted for days. As THC molecules break down in the body, they become smaller molecules known as THC metabolites. The major, excreted glucuronic metabolite through the urine is THC-COOH glucuronide. The urine tests are not looking for the specific THC isomer that goes in the body, they are instead looking for the THC-COOH metabolites that come out. 

 

As with many cannabinoids, much research still needs to be completed and considered on delta-8-THC before we can fully understand its full potential. What we do know is that there is a lot of promise as a less psychotropic alternative to delta-9-THC. 

 

Disclaimer

The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

 

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.

 

Categories
Blog Education Featured

Cannabis legislation a priority to U.S. House and Senate members in 2021

With the start of the new year, several bills are expected to be introduced by Congress in the name of cannabis legislation and reform. Two congressional bills have, in fact, already been filed but Rep. Greg Steube (R-FL). The first introduced bill is identical to the previously proposed, The Marijuana 1-to-3 Act of 2019. This measure would reschedule Marijuana to a Schedule III with the goal to increase research on the therapeutic effects. The second filed legislation is The Veterans Cannabis Use for Safe Healing Act, to “prohibit the Secretary of Veterans Affairs from denying a veteran benefits due to the use of medical marijuana in states where the substance is legal.” 

 

These introduced bills show promise, but advocates are looking for more change in terms of cannabis reform, especially considering that the Democrats now have control of both the House and the Senate. Last year the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act was introduced to federally legalize marijuana. While this passed through the House it did not pass the Senate. To speak to the re-approach of the bill, Rep. Earl Blumenauer (D-OR) stated on his Twitter on February 1st, “We look forward to working with the Senate to refine the bill, advance its core criminal justice and restorative justice provisions, and end the failed federal prohibition of cannabis once and for all.” 

 

Senate Majority Leader Chuck Schumer (D-NY) has stated that cannabis reform is a priority for 2021. On February 1st he announced on Twitter that “The War on Drugs has been a war on people, and particularly people of color. Ending the federal marijuana prohibition is necessary to right the wrongs of this failed war.” Schumer is working alongside Sen. Cory Booker (D-NJ) and Senate Finance Committee Chairman Ron Wyden (D-OR) to release draft legislation in the coming weeks, detailing the proposed policy change at a federal level. Their released, joint statement shows promise for “comprehensive reform to ensure restorative justice, protect public health and implement responsible taxes and regulations.”

 

 

 

Realm of Caring Foundation (RoC), is a 501(c)3 nonprofit organization that was established by parents in 2013 to support families who were out of medical options. By creating educational resources, conducting research, and assisting families with data-rich answers to their questions, RoC continues to be a leader in the cannabinoid (cannabis/hemp) field. RoC’s no-cost Care Team has served more than 65,000 clients worldwide and supports a network of over 2,000 medical professionals. To learn more about participating or to donate to this cause, visit www.realmofcaring.org or call 1-888-210-3772.    

Categories
Blog Education

Cannabinoid therapy for Autism Spectrum Disorders (ASD)

Observational studies and trials in both humans and rodents in recent years have reported the beneficial use of cannabinoids in the form of cannabidiol (CBD) cannabis and hemp extracts as a therapeutic potential for ASD. In addition to being beneficial, these studies have also reported that, even in adolescents, the side effects of the cannabis extracts were either nonexistent or less frequent than those who reported drugs that are traditionally used for ASD, ADHD, sleep disorders, or epilepsy. 

 

When considering ASD, there are currently no defined drugs or psychotherapeutic approaches capable of extensively improving the quality of life, social skills, and cognitive functioning of the most severe cases. While the currently available drugs may mitigate certain symptoms, the effectiveness is, reportedly, limited and may have undesirable side effects. So, how is it then, that cannabinoid therapy may work differently with the body to possibly provide therapeutic benefit? To understand the difference of cannabinoid therapy in comparison to the available, conventional treatments it is helpful to first gain an understanding of the Endocannabinoid System (ECS) these plant cannabinoids are interacting with.

 

The ECS is the largest neurotransmitter system in the body, involved in regulating nearly every physiological process. It is composed of two receptors called CB1 and CB2 receptors, endocannabinoids, and metabolizing enzymes. Two key endocannabinoids have been identified as Anandamide (AEA) and 2-arachidonoylglycerol (2-AG). These endocannabinoids are responsible for activating the CB1 and CB2 receptors that are found throughout our bodies and brains. Once endocannabinoids activate these receptors, physiological actions take place. 

 

Research has shown that one thing individuals with ASD have in common, is that AEA levels are more reduced than in non-ASD individuals. This is a concept known as clinical endocannabinoid deficiency (CED), a theory presented in 2001 and more thoroughly explored in 2004, where decreased AEA levels were found to be associated with a lower pain threshold, post traumatic stress disorder (PTSD), gastrointestinal disorders, and inflammation. 

 

When experiencing a deficiency of endocannabinoids, such as decreased AEA levels, research suggests the benefit of naturally increasing levels with the modulating cannabis compound, CBD. By supplementing with phytocannabinoids, like CBD, we may be able to mimic the action of those endocannabinoids to fill in gaps of deficiency, which means those decreased levels may become normalized. 

 

Since discovering this connection between decreased AEA levels and ASD, it has been shown that AEA modulation may potentially improve some aspects of behaviors, such as anxiety, without affecting social behaviors. There have even been suggestions that increasing AEA activity at CB1 receptor sites may actually lead to prosocial behavior. AEA modulation has also been linked as an important role in those with epileptic conditions. 

 

In addition to modulating AEA levels, CBD has been researched for its modulating benefits in other physiological processes. This includes how effectively our body may facilitate the serotonin it creates, allowing for more regulation of our moods. It also includes the shifting of glutamate and inhibitory y-aminobutyric acid (GABA), which may regulate excitatory and inhibitory neurotransmission in the brain. Due to the many processes CBD may modulate, participants in studies have seen a reduction in anxiety, cognitive impairment, and discomfort factors as well as an increase in the processing of emotional information.

 

Getting started with cannabinoid therapy can be overwhelming, especially when considering a neurodevelopmental disorder as complex as ASD. Most of the evidence of the efficacy of CBD with ASD comes from anecdotal and observational data; so although findings conclude that the cannabinoid is safe and may provide relief for associated symptoms, there is plenty of room for further clinical research to explore the full therapeutic potential of CBD, as well as the ability of other cannabinoids to potentiate its ability. 

 

If you are seeking data-driven answers to your questions about this cannabinoid therapy and ASD, Realm of Caring (RoC) can help. RoC has 8 years of collected data and research based on individuals utilizing plant-based therapies. They can guide you through product selection, dosing and administration, how to talk with your doctor, and the results individuals are realizing.

 

The RoC Care Team is here to assist. They care a lot about helping you to find success. Reach them by calling (719) 347-5400, emailing info@realmofcaring.org, or by scheduling appointment.

 

 

Disclaimer
The Realm of Caring Foundation specifically invokes the first amendment rights of freedom of speech and of the press without prejudice. These statements have not been evaluated by the food and drug administration. the products discussed are not intended to diagnose, cure, prevent or treat any disease. Realm of Caring always recommends when and wherever possible that licensed local healthcare professionals be consulted.

The Realm of Caring Foundation is an independent nonprofit with its own governing board. We do not produce or sell cannabinoid products, nor do we receive funds from the sale of other company’s products.